The Pace of Innovation in Diagnostic Testing
Posted in Cost and Quality Improvement, Douglas Moeller, MD, Personalized Medicine/Molecular Diagnostics (MDx), Point-of-Care Decision Management on May 28th, 2010 by admin – Be the first to commentIn this interview with Mabel Jong at the 7th World Health Care Congress, Dr. Moeller discusses the challenges of accurate coding for new tests and the need for standard decision protocols. In addition, he suggests that making information about innovations available to patients can lead to better outcomes because patients can be more involved in their own care decisions.

